RASD2 and tauopathy: Many substrates of lonafarnib have been identified among which Rhes participates in tauopathy (Hernandez et al., 2019; Ehrenberg et al., 2021) and is involved in ISP signaling (Bang et al., 2012; Harrison et al., 2013).